FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return zbecker Wed, 05/04/2022 – 15:29 More: FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return Source: fierce
read moreTakeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion aliu Wed, 05/04/2022 – 11:21 More: Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion Source: fierce
read moreAmarin, after 33% revenue decline, aims to ‘stabilize’ US sales and grow in Europe zbecker Wed, 05/04/2022 – 11:16 More: Amarin, after 33% revenue decline, aims to 'stabilize' US sales and grow in Europe Source: fierce
read moreRegeneron counts on Eylea’s track record to fend off Roche rival Vabysmo kdunleavy Wed, 05/04/2022 – 11:07 More: Regeneron counts on Eylea's track record to fend off Roche rival Vabysmo Source: fierce
read moreModerna tunes booster pitch ahead of potential shift to private COVID vaccine market this fall fkansteiner Wed, 05/04/2022 – 10:10 More: Moderna tunes booster pitch ahead of potential shift to private COVID vaccine market this fall Source: fierce
read moreApproval for Kymriah follows a positive CHMP opinion and is applicable to all 27 EU member states More: Novartis Kymriah receives EC approval for lymphoma treatment Source: News
read more© 1994 - 2022 B.M. Pharmaceuticals